- Home
- Publications
- Publication Search
- Publication Details
Title
Pazopanib for the treatment of advanced renal cell cancer
Authors
Keywords
-
Journal
Expert Opinion on Orphan Drugs
Volume 2, Issue 6, Pages 605-616
Publisher
Informa Healthcare
Online
2014-05-09
DOI
10.1517/21678707.2014.912579
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Phase I Study of Pazopanib in Patients with Advanced Solid Tumors and Hepatic Dysfunction: A National Cancer Institute Organ Dysfunction Working Group Study
- (2013) S. I. Shibata et al. CLINICAL CANCER RESEARCH
- Pazopanib as Second-Line Treatment After Sunitinib or Bevacizumab in Patients With Advanced Renal Cell Carcinoma: A Sarah Cannon Oncology Research Consortium Phase II Trial
- (2013) John D. Hainsworth et al. Clinical Genitourinary Cancer
- Hepatotoxicity of Tyrosine Kinase Inhibitors: Clinical and Regulatory Perspectives
- (2013) Rashmi R. Shah et al. DRUG SAFETY
- A randomised, double-blind phase III study of pazopanib in patients with advanced and/or metastatic renal cell carcinoma: Final overall survival results and safety update
- (2013) Cora N. Sternberg et al. EUROPEAN JOURNAL OF CANCER
- Targeting angiogenesis in renal cell carcinoma
- (2013) Edwin M Posadas et al. EXPERT OPINION ON PHARMACOTHERAPY
- Pazopanib versus Sunitinib in Metastatic Renal-Cell Carcinoma
- (2013) Robert J. Motzer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Combination Therapy in Metastatic Renal Cell Cancer
- (2013) Alain Ravaud et al. SEMINARS IN ONCOLOGY
- Safety and Activity of Anti–PD-L1 Antibody in Patients with Advanced Cancer
- (2012) Julie R. Brahmer et al. NEW ENGLAND JOURNAL OF MEDICINE
- Safety, Activity, and Immune Correlates of Anti–PD-1 Antibody in Cancer
- (2012) Suzanne L. Topalian et al. NEW ENGLAND JOURNAL OF MEDICINE
- Global cancer statistics
- (2011) Ahmedin Jemal et al. CA-A CANCER JOURNAL FOR CLINICIANS
- The Epidemiology of Renal Cell Carcinoma
- (2011) Börje Ljungberg et al. EUROPEAN UROLOGY
- Pazopanib for the treatment of renal cancer
- (2011) Brian Rini et al. EXPERT OPINION ON PHARMACOTHERAPY
- Combination Therapy for Renal Cell Cancer: What Are Possible Options?
- (2011) Napoleon Santos et al. ONCOLOGY
- Pazopanib
- (2010) Mark Sanford et al. BIODRUGS
- Pazopanib in Locally Advanced or Metastatic Renal Cell Carcinoma: Results of a Randomized Phase III Trial
- (2010) Cora N. Sternberg et al. JOURNAL OF CLINICAL ONCOLOGY
- Phase I Trial of Pazopanib in Patients with Advanced Cancer
- (2009) H. I. Hurwitz et al. CLINICAL CANCER RESEARCH
- Efficacy and Safety of Pazopanib in Patients With Metastatic Renal Cell Carcinoma
- (2009) Thomas E. Hutson et al. JOURNAL OF CLINICAL ONCOLOGY
- Resistance to targeted therapy in renal-cell carcinoma
- (2009) Brian I Rini et al. LANCET ONCOLOGY
- Pazopanib
- (2009) Ronald M. Bukowski et al. NATURE REVIEWS DRUG DISCOVERY
Become a Peeref-certified reviewer
The Peeref Institute provides free reviewer training that teaches the core competencies of the academic peer review process.
Get StartedAsk a Question. Answer a Question.
Quickly pose questions to the entire community. Debate answers and get clarity on the most important issues facing researchers.
Get Started